Status:

UNKNOWN

Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia

Lead Sponsor:

Sir Run Run Shaw Hospital

Conditions:

Schizophrenia

Eligibility:

All Genders

18+ years

Phase:

EARLY_PHASE1

Brief Summary

Schizophrenia is a group of severe mental disorders of unknown etiology, with significant abnormalities in mental activities such as cognition, thinking, emotion, and behavior, and lead to obvious occ...

Detailed Description

The project plans to include 80 non-smoking patients with schizophrenia. If you meet the study enrollment requirements and agree to participate in the study, we will number you and establish a medical...

Eligibility Criteria

Inclusion

  • Using the DSM-V International Neuropsychiatric Jane's Interview Questionnaire (M.I.N.I.);
  • Meet the DSM-V symptom criteria for the diagnosis of schizophrenia;
  • Course of illness for 5 years and less;
  • The cumulative number of cigarettes smoked in the past is less than 100;
  • Lower secondary school or above education level;
  • Han Chinese;
  • years old≥ 18 years old;
  • Right hand;
  • Voluntarily join the study and sign an informed consent form.

Exclusion

  • Schizophoratic disorder, bipolar disorder, mental retardation, anxiety spectrum disorder, psychotic disorder caused by drugs, alcohol and other psychoactive substances that meet the diagnostic criteria of DSM-V;
  • Have a history of cerebral organic diseases or head injury;
  • have a history of alcohol and drug dependence;
  • history of impaired consciousness for more than 5 minutes;
  • History of endocrine diseases such as thyroid dysfunction and diabetes mellitus;
  • Those who have serious abnormalities in blood picture, heart, liver and kidney function after examination;
  • pregnant and nursing women;
  • people who have been treated with electroconvulsiveness;
  • There are contraindications to magnetic resonance.

Key Trial Info

Start Date :

March 22 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 15 2023

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT05301660

Start Date

March 22 2022

End Date

February 15 2023

Last Update

March 31 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.